BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31917657)

  • 1. Role of Multimodality Imaging in Gastroesophageal Reflux Disease and Its Complications, with Clinical and Pathologic Correlation.
    Manning MA; Shafa S; Mehrotra AK; Grenier RE; Levy AD
    Radiographics; 2020; 40(1):44-71. PubMed ID: 31917657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus Statement of Society of Abdominal Radiology Disease-Focused Panel on Barium Esophagography in Gastroesophageal Reflux Disease.
    Levine MS; Carucci LR; DiSantis DJ; Einstein DM; Hawn MT; Martin-Harris B; Katzka DA; Morgan DE; Rubesin SE; Scholz FJ; Turner MA; Wolf EL; Canon CL
    AJR Am J Roentgenol; 2016 Nov; 207(5):1009-1015. PubMed ID: 27490234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GERD and its complications. The pathogenic relationship between symptoms and disease progression.
    Pisegna JR
    Postgrad Med; 2001 Oct; Spec No():19-23. PubMed ID: 11868427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
    Shaheen N; Ransohoff DF
    JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroesophageal Reflux Disease.
    Kellerman R; Kintanar T
    Prim Care; 2017 Dec; 44(4):561-573. PubMed ID: 29132520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroesophageal reflux disease: From pathophysiology to treatment.
    Herbella FA; Patti MG
    World J Gastroenterol; 2010 Aug; 16(30):3745-9. PubMed ID: 20698035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal Reflux Disease: A Review.
    Maret-Ouda J; Markar SR; Lagergren J
    JAMA; 2020 Dec; 324(24):2536-2547. PubMed ID: 33351048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
    Stein HJ; Kauer WK; Feussner H; Siewert JR
    J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications.
    Hampel H; Abraham NS; El-Serag HB
    Ann Intern Med; 2005 Aug; 143(3):199-211. PubMed ID: 16061918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations and complications of gastroesophageal reflux disease (GERD).
    Malfertheiner P; Hallerbäck B
    Int J Clin Pract; 2005 Mar; 59(3):346-55. PubMed ID: 15857335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of gastroesophageal reflux and Barrett esophagus].
    von Schrenck T
    Zentralbl Chir; 2000; 125(5):414-23. PubMed ID: 10929625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging concepts of bile reflux in the constellation of gastroesophageal reflux disease.
    Kauer WK; Stein HJ
    J Gastrointest Surg; 2010 Feb; 14 Suppl 1():S9-16. PubMed ID: 19756880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of gastroesophageal reflux disease and impact of treatment in symptomatic young patients.
    Bonavina L; Fisichella PM; Gavini S; Lee YY; Tatum RP
    Ann N Y Acad Sci; 2020 Dec; 1481(1):117-126. PubMed ID: 32266986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reflux, Barrett's, and adenocarcinoma of the esophagus: can we disrupt the pathway?
    DeMeester SR
    J Gastrointest Surg; 2010 Jun; 14(6):941-5. PubMed ID: 20094815
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
    Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
    Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett esophagus: epidemiology, pathogenesis, diagnosis, and management.
    Estores D; Velanovich V
    Curr Probl Surg; 2013 May; 50(5):192-226. PubMed ID: 23601575
    [No Abstract]   [Full Text] [Related]  

  • 18. The continuum of GERD complications.
    Fennerty MB
    Cleve Clin J Med; 2003 Nov; 70 Suppl 5():S33-50. PubMed ID: 14705380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
    Schlottmann F; Molena D; Patti MG
    Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between obesity and GERD: a review of the epidemiological evidence.
    El-Serag H
    Dig Dis Sci; 2008 Sep; 53(9):2307-12. PubMed ID: 18651221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.